Foundation Venture, affiliated with New Jersey Health Foundation, announces backing for life sciences research firm MentiNova.

Foundation has committed up to $500,000 to advance this research and development to MentiNova.

The five million shares to be sold in its initial public offering (IPO) will be issued at $9 to $10 each compared to a $13 to $15 range previously announced, according to its regulatory filing.

Spun out from Anglo-Dutch consumer goods conglomerate Unilever in 1995, BAC said its shareholders included Unilever Ventures and family office FF&P Private Equity.

New Jersey Health Foundation and the University of Medicine and Dentistry of New Jersey collaborate on new venture model to commercialise university IPs.

Peter Bisgaard, partner with Novo Ventures, joined the board of Ceterix, which was founded in October 2010 as SuturePro Technologies based on the inventions of Justin Saliman.

De Montfort University and Ithaka Life Sciences launch drug discovery spin out.